Human Growth Hormone; an Important Hormone that Helps Maintain Tissues/Organs throughout Life

Human Growth Hormone
Human Growth Hormone

Human Growth Hormone is a naturally occurring hormone produced by a pituitary gland (a small pea-sized gland that plays a major role in regulating vital body functions and general wellbeing). It is important for growth, cell regeneration, and cell reproduction. Growth hormone helps build, maintain, and repair healthy tissue in the brain & other organs. The main function of the pituitary gland is to produce and release several hormones that help carry out important bodily functions, such as growth, metabolism, and reproduction.

Human Growth Hormone is a naturally occurring hormone that regulates body metabolism. It is produced in the brain and secreted throughout the body. As a natural part of the body, hGH helps promote healthy growth and maintain tissue tissues throughout the lifespan. While the body produces growth hormone naturally, it slows down in the middle age, leading to a decline in the production. Due to this natural slowdown, increasing interest in growth hormone and synthetic forms of the hormone have risen.

Functions of Human Growth Hormone include increased height during childhood, strengthens and increases mineralization of the bone, increases calcium retention, stimulates growth of all internal organs excluding the brain, increases protein synthesis, promotes lipolysis, increases muscle mass through sarcomere hypertrophy, plays a vital role in homeostasis, stimulates the immune system, reduces uptake of glucose by liver, and increases DE iodination of T4 to T3. Growth hormone is stored and secreted in the pituitary gland.

Growth hormone fuels childhood growth and helps maintain tissues and organs throughout life. However, the pituitary gland slowly reduces the amount of growth hormone it produces. It is marketed, distributed, and prescribed off-label to adults to replenish declining Human Growth Hormone Market levels and reverse age-related bodily deterioration. In January 2021, OPKO Health announced that its partner, Pfizer Japan Inc., submitted a New Drug Application to the Ministry of Health, Labour, and Welfare in Japan for somatrogon, a long-acting recombinant hGH for the treatment of pediatric patients with growth hormone deficiency (GHD).

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more